Innocan Pharma Corporation (TSE:INNO) has released an update.
Innocan Pharma Corporation has reported a significant pre-clinical success with their liposomal-CBD injection, which restored mobility and provided pain relief to an amputee female donkey suffering from laminitis. The treatment saved the donkey, named Miri, from euthanasia, demonstrating the potential of Innocan’s therapy for both animal and possibly human applications in pain management and disease treatment. The company is known for its innovative drug delivery technologies and consumer wellness products aimed at improving quality of life.
For further insights into TSE:INNO stock, check out TipRanks’ Stock Analysis page.
